Search

AF solution

Chevron

A Pancreatic Cancer Organoid-in-Matrix Platform Shows Distinct Sensitivities to T Cell Killing

The study addresses the challenges of poor treatment responses in pancreatic ductal adenocarcinoma (PDAC) due to tumor heterogeneity and an immunosuppressive tumor microenvironment (TME). It introduces the InterOMaX model system, a 3D co-culture platform that mimics matrix-dependent cellular crosstalk to investigate T cell responses in PDAC. This system uses a customizable matrix and organoid-in-matrix positioning to co-culture PDAC cells with T cells and stromal cells. By detecting and analyzing PDAC cell populations with varying sensitivity to T cell killing, the platform enables identification and validation of gene candidates for T cell resistance, advancing the understanding of cancer cell-intrinsic resistance phenotypes in PDAC.

Keywords: Pancreatic cancer organoid, T-cell killing, pancreatic ductal adenocarcinoma, tumor microenvironment

Important Details

  • Validity: Until September 30th, 23:59 German time.
  • Applicability: One experiment per indication (Oncology, Skin & Cosmetics, Organoids).
  • Flexibility: Use the coupon unlimited times until the event ends.
  • Conditions: Applies when proceeding with a contract.

Log in to MyLab and

download your gift voucher from the ‘Vouchers’ menu!

Thank you for your continued trust and partnership.
We look forward to serving you with excellence.